Similar articles

• Optimizing protection against influenza in children eligible for the vaccine for children program.

  Hull HF, O'Connor H. Hull HF, et al. Pediatr Infect Dis J. 2010 Oct;29(10):910-4. doi: 10.1097/INF.0b013e3181e05579. Pediatr Infect Dis J. 2010. PMID: 20431426
• Inactivated influenza virus vaccines in children.

  Ruben FL. Ruben FL. Clin Infect Dis. 2004 Mar 1;38(5):678-88. doi: 10.1086/382883. Epub 2004 Feb 17. Clin Infect Dis. 2004. PMID: 14986252 Review.
• The use of inactivated influenza vaccine in children.

  Wright PF. Wright PF. Semin Pediatr Infect Dis. 2006 Oct;17(4):200-5. doi: 10.1053/j.spid.2006.08.004. Semin Pediatr Infect Dis. 2006. PMID: 17055371 Review.
• [Results of a 3-year survey of persons inoculated with inactivated inflenza vaccine (IIV). II. The immunological effectiveness of IIV and its comparison with the epidemiological].

  Mukhina LP, Kozlova NA, Rykushin IuP, Bichurina MA, Polzik TP. Mukhina LP, et al. Tr Inst Im Pastera. 1979;52:71-5. Tr Inst Im Pastera. 1979. PMID: 162089 Russian. No abstract available.
• Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.

  Fleming DM, Crovari P, Wahn U, Klemola T, Schlesinger Y, Langussis A, Øymar K, Garcia ML, Krygier A, Costa H, Heininger U, Pregaldien JL, Cheng SM, Skinner J, Razmpour A, Saville M, Gruber WC, Forrest B; CAIV-T Asthma Study Group. Fleming DM, et al. Pediatr Infect Dis J. 2006 Oct;25(10):860-9. doi: 10.1097/01.inf.0000237797.14283.cf. Pediatr Infect Dis J. 2006. PMID: 17006278 Clinical Trial.